Blog Archives

Personomics: The Missing Link from Precision Medicine to Personalized Medicine

October 21, 2017 – Just seen on PubMed:

Ziegelstein RC

 

J Pers Med 2017 Oct;7(4)

PMID: 29035320

Abstract

Clinical practice guidelines have been developed for many common conditions based on data from randomized controlled trials.

Read more ›

Tags: , , , ,

The Clinical and Economic Impact of Inaccurate EGFR Mutation Tests in the Treatment of Metastatic Non-Small Cell Lung Cancer

June 30, 2017 – The below citation from PubMed addresses an vey important issue associated with genetic testing in theragenomic and personalized medicine. It is the question if the genetic test used to stage, classify, or determine treatability of a disease with a given drug is accurate.

Read more ›

Tags: , , , , , , , ,

The Trump Administration and the environment: Impact on human health

March 06, 2017 – The following article by Samet et. al. discusses the impact that newly sought after legislation and budgeting cuts by the Trump Administration may have on environmental health. Usually, thasso post does not address politically based issues; in the case of the intention by the Trump Administration to de facto dismantle EPA,

Read more ›

Tags: , , , ,

Hot topic: Minimizing the health risks from legalization of Cannabis

March 2, 2017 – This post is about the health risks associated with recreational use of Cannabis and all the aspects that come along with its legalization in at least some states in the United States. The post simply reproduces the article in the New England Journal of Medicine (NEJM) by Beau Kilmer,

Read more ›

Tags: , , , ,

Epigenetics in Cancer: A Hematological Perspective

October 11, 2016 – Here, you will find an overview article on applied epigenetics and its role when it comes to cancer. This is heavy material to read and therefore most probably geared toward the science-inclined  readers of thasso post and patients in thasso’s patient networks.

Read more ›



The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

alz-ad-iSeptember 09.  2016 – The pre-clinical animal model and Phase 1b placebo-controlled study in prodromal and mild Alzheimer Disease (AD) patients (n=165), both demonstrate that aducanumab reduced amyloid-beta in the brain and the reduction was dose-dependent. Amyloid-beta plaque is associated with the development of AD and it has for a long time been hypothesized that removing it may slow the clinical decline of people who have AD.

Read more ›

Tags: , , , ,

Adverse clinical outcome associated with mutations in colorectal cancers of African Americans

Colon Cancer in AASeptember 04, 2016 – Case Comprehensive Cancer Center researchers, a research collaboration which includes University Hospitals Seidman Cancer Center and Case Western Reserve University, who last year identified new gene mutations unique to colon cancers in African Americans, have found that tumors with these mutations are highly aggressive and more likely to recur and metastasize.

Read more ›

Tags: , , , , , , ,

Orlistat: Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers

August 30, 2016 – The present article which just appeared in August 2016 issue of  PLOS Medicine illustrates how the inaccurate and biased to say the least the assessment and the reporting of adverse drug reactions by pharmaceutical companies throughout study protocols, investigators brochures,

Read more ›

Tags: , , , , , ,

Actionable pharmacogenetic markers for prediction and prognosis in breast cancer

Sacco K, Grech G

EPMA J 2015;6(1):15

PMID: 26203310

Abstract

Breast cancer is a heterogeneous disease that necessitates proper patient classification to direct surgery, pharmacotherapy, and radiotherapy. Despite patients within the same subgroup receiving similar pharmacotherapy, substantial variation in clinical outcomes is observed.

Read more ›

Tags: , , , , , , , , , , , , ,

Pharmacogenomics for infectious diseases in sub-Saharan Africa: Successes and opportunities

August 14, 2016 – The PubMed-article below illustrates how pharmacogenetics and/or pharmacogenomics-guided drug therapy (i.e., theragenomic medicine) has its place and impact on patients and healthcare systems in African countries when it comes to large disease burdens such as in HIV/AIDS, Tuberculosis (TB), and malaria.

Read more ›

Tags: , , , , , , ,

thasso: conditions

thasso: tweets

thasso post: magazine

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • Descendants of early Europeans and Africans in US carry Native American genetic legacy September 19, 2019
    Many people in the U.S. do not belong to Native American communities but still carry bits of Native American DNA, inherited from European and African ancestors who had children with indigenous individuals during colonization and settlement. In a new study published 19th September in PLOS Genetics, Andrew Conley of the Georgia Institute of Technology and […]
  • IGF1 gene is essential to adult tendon growth, animal study shows September 19, 2019
    Tendon injuries are among the most common injuries seen in athletes at all levels, from weekend warriors to professional basketball players. For those who rupture their tendons, returning to the same level of physical activity they enjoyed before the injury is rare.
  • Researchers create new protocol to improve gene therapy tool production September 19, 2019
    A method to create a faster and lower cost alternative for a gene therapy tool has been developed by Boston University School of Medicine (BUSM) researchers.
  • Genetic variants with possible positive implications for lifestyle September 19, 2019
    A German and British research team lead by Technical University of Munich (TUM) has examined the interplay between genetics, cardiovascular disease and educational attainment in a major population study. Genetic variants which had been linked to educational attainment in other studies were observed in the subjects. The researchers found that these variants also had implications […]
  • Scientists develop new methodology to genetically modify lab mice and human cells September 19, 2019
    A team led by Cedars-Sinai has designed a rapid method to genetically alter laboratory mice and then used this method to produce personalized animal models of pediatric glioma, an aggressive type of malignant brain cancer in children.
Top